Predicted protein targets (top 13)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CYP19A1 | P11511 | 3/20 | 0.45 |
| ▸ | LDHA | P00338 | 1/20 | 0.41 |
| ▸ | DRD2 | P14416 | 5/20 | 0.36 |
| ▸ | DRD3 | P35462 | 5/20 | 0.36 |
| ▸ | SIRT2 | Q8IXJ6 | 1/20 | 0.35 |
| ▸ | RIPK1 | Q13546 | 1/20 | 0.35 |
| ▸ | FFAR1 | O14842 | 1/20 | 0.34 |
| ▸ | FADS1 | O60427 | 2/20 | 0.34 |
| ▸ | NPC1 | O15118 | 1/20 | 0.33 |
| ▸ | RAB9A | P51151 | 1/20 | 0.33 |
| ▸ | MAOB | P27338 | 2/20 | 0.32 |
| ▸ | PNMT | P11086 | 1/20 | 0.32 |
| ▸ | AR | P10275 | 1/20 | 0.32 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL31346011 | 0.81 | FFAR1 (0.36) | CYP19A1SIRT2FFAR1NPC1RAB9A | |
| SCHEMBL31345995 | 0.81 | CYP19A1 (0.45) | CYP19A1LDHADRD2DRD3SIRT2 | |
| SCHEMBL31346117 | 0.81 | CYP19A1 (0.45) | CYP19A1LDHADRD2DRD3SIRT2 | |
| SCHEMBL31346093 | 0.80 | CYP19A1 (0.46) | CYP19A1LDHADRD2DRD3FADS1 | |
| SCHEMBL31346020 | 0.77 | LDHA (0.49) | CYP19A1LDHADRD2DRD3SIRT2 | |
| SCHEMBL31346146 | 0.76 | LDHA (0.46) | CYP19A1LDHADRD2DRD3SIRT2 | |
| SCHEMBL31346053 | 0.76 | CYP19A1 (0.42) | CYP19A1LDHADRD2DRD3SIRT2 | |
| SCHEMBL31346143 | 0.76 | LDHA (0.46) | CYP19A1LDHADRD2DRD3SIRT2 | |
| SCHEMBL31346021 | 0.73 | CYP19A1 (0.42) | CYP19A1LDHADRD2DRD3FFAR1 | |
| SCHEMBL31346031 | 0.73 | LDHA (0.46) | CYP19A1LDHADRD2DRD3SIRT2 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-4712967-A2 | G-PROTEIN COUPLED RECEPTOR ANTAGONIST | Enveda Therapeutics, Inc. (US) | 2026-03-25 | — | — | EP | disclosed |
| WO-2024239000-A2 | G-PROTEIN COUPLED RECEPTOR ANTAGONIST | ENVEDA THERAPEUTICS, INC. (US) | 2024-11-21 | — | — | WO | disclosed |